Correlation of histology to clinical rejection reversal: A Thymoglobulin Multicenter Trial report

Kidney International

Volumn 55, Issue 6, 1999, Pages 2415-2422

  Gaber, Lillian W ^a,b,c   Moore, Linda W ^a,b,c   Gaber, A Osama ^a,b,c   Tesi, Raymond J ^a,b,c   Meyer, Jayne ^a,b,c   Schroeder, Timothy J ^a,b,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b GENZYME CORPORATION   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Acute rejection; Atgam; Banff histology; Biopsy; Kidney transplant; Rejection therapy

Indexed keywords

THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033065020     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00494.x     Document Type: Article

References (24)

1. 1. Gaber AO, Moore LW, Schroeder TJ: Observations on recovery of renal function following treatment for acute rejection. Am J Kidney Dis 31(Suppl):S47-S59, 1998
2. 2. Guttmann RD, Soulillou JP, Moore LW, First MR, Gaber AO, Pouletty PO, Schroeder TJ: Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejection. Am J Kidney Dis 31(Suppl):S40-S46, 1998
3. 3. Gaber LW, Moore LW, Alloway RR, Flax SD, Shokouh-Amiri MH, Schroeder TJ, Gaber AO: Correlation between Banff classification, acute renal rejection scores and reversal of rejection. Kidney Int 49:481-487, 1996
4. 4. Howard RJ, Condie RM, Sutherland DER, Simmons RL, Najarian JS: The use of antilymphoblast globulin in the treatment of renal allograft rejection. Transplantation 24:419-423, 1977
5. 5. Ortho Multicenter Transplant Study Group: A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 313:337-342, 1985
6. 6. Waid TH, Lucas BA, Thompson JS, Munch LC, Brown S, Kryscio R, Prebeck R, Vanhoy MA, Jezek D: Treatment of acute rejection with anti-T-cell antigen receptor complex α β (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: Results of a prospective randomized double-blind trial. Transplant Proc 23:1062-1065, 1991
7. 7. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Häyry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozumi K, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani R, Von Willebrand E, Yamaguchi Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44:411-422, 1993
8. 8. Colvin RB, Cohen AH, Saiontz C, Bonsib S, Buick M, Burke B, Carter S, Cavallo T, Haas M, Lindblad A, Manivel JC, Nast CC, Salomon D, Weaver C, Weiss M: Evaluation of pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 8:1930-1941, 1997
9. 9. Woodle ES, Cronin D, Newell KA, Millis JM, Bruce DS, Piper JB, Haas M, Josephson MA, Thistlethwaite JR: Tacrolimus therapy for refractory acute renal allograft rejection: Definition of the histologic response by protocol biopsies. Transplantation 62:906-910, 1996
10. 10. Burdick JF, Beschorner WE, Smith WJ, McGraw D, Bender WL, Williams GM, Solez K: Characteristics of early routine renal allograft biopsies. Transplantation 38:679-684, 1991
11. 11. Rush DN, Henry SF, Jeffrey JR, Schroeder TJ, Gough J: Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 57:208-211, 1994
12. 12. Gaber AO, First MR, Tesi RJ, Gaston RS, Mendez R, Mulloy LL, Light JA, Gaber LW, Squiers E, Taylor RJ, Neylan JF, Steiner RW, Knechtle S, Norman DJ, Shihab F, Basadonna G, Brennan DC, Hodge EE, Kahan BD, Kahana L, Steinberg S, Woodle ES, Chan L, Ham JM, Stratta RJ, Wahlstrom E, Lamborn KR, Horn HR, Berger Moran H, Pouletty P, Schroeder TJ: Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation. Transplantation 66:29-37, 1998
13. 13. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55:752-757, 1993
14. 14. Flechner SM, Modlin CS, Serrano DP, Goldfarb DA, Papajcik D, Mastroianni B, Goormastic M, Novick AC: Determinants of chronic renal allograft rejection in cyclosporine-treated recipients. Transplantation 62:1235-1241, 1996
15. 15. Matas AJ, Gillingham KJ, Payne WD, Najarian JS: The impact of an acute rejection episode on long-term renal allograft survival (11/2). Transplantation 57:857-859, 1994
16. 16. Cecka JM: Early rejection determining the fate of renal transplants. Transplant Proc 23:1263-1264, 1991
17. 17. Tesi RJ, Elkhammas EA, Henry M, Ferguson RM: Acute rejection episodes: Best predictor of long-term primary cadaveric renal transplant survival. Transplant Proc 25:901-902, 1993
18. 18. Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Gores PF, Gruessnor RW, Najarian JS: Early versus late acute renal allograft rejection: Impact on chronic rejection. Transplantation 55:993-995, 1993
19. 19. Kerr PG, Atkins RC: The effects of OKT3 therapy on infiltrating lymphocytes in rejecting renal allografts. Transplantation 48:33-36, 1989
20. 20. Gaber LW, Moore LW, Alloway RR, Flax S, Gaber AO: Correlation between Banff classification, acute renal rejection scores and reversal of rejection. Kidney Int 49:481-487, 1996
21. 21. Isoniemi HM, Krogerus L, Von Willebrand E, Taskinen E, Ahonen J, Hayry P: Histopathological findings in well-functioning, long-term allografts. Kidney Int 41:155-160, 1992
22. 22. Rush D, Jeffrey J, Trpkov K, Solez K, Gough J: Effect of subclinical rejection on renal allograft histology and function at 6 months. Transplant Proc 28:494-495, 1996
23. 23. Rush DN, Jeffrey JR, Gough J: Sequential protocol biopsies in renal transplant patients. Transplantation 59:511-514, 1995
24. 24. Serón D, Moreso F, Bover J, Condom E, Gil-Vernet S, Canas C, Fulladosa X, Torras J, Carrera M, Grinyó JM, Alsina J: Early protocol renal allograft biopsies and graft outcome. Kidney Int 51:310-316, 1997